Clinical trials

Clinical trials are an important part of the process of developing new medicines for patients. A type of scientific research study, they explore whether a potential new medicine is safe to use and will work as intended in humans. Those who choose to participate in clinical trials are an important part of vital research that could change the course of disease and help improve lives.

Our clinical trials in

Huntington’s disease

Our clinical trials in

Huntington’s disease

Trial
Recruiting

We are currently recruiting adults with early manifest Huntington’s disease (HD) who carry a SNP at the rs362307 (“SNP1”) location for a Phase 1b/2a clinical trial.

Learn more about Wave trials for HD at clinicaltrials.gov

Trial
Recruiting

We are currently recruiting adults with early manifest Huntington’s disease (HD) who carry a SNP at the rs362331 (“SNP2”) location for a Phase 1b/2a clinical trial.

Learn more about Wave trials for HD at clinicaltrials.gov

Our clinical trials in

Additional Programs in Development

Additional Programs in Development

Wave is advancing its C9orf72 preclinical program to potentially treat amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).